Related Experiment Video

Updated: Aug 13, 2026

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

Chloramphenicol 1. Hazards of use and the current regulatory environment

S W Page1

  • 1Australian Veterinary Association Subcommittee on Therapeutics, Artarmon, New South Wales.

Australian Veterinary Journal
|January 1, 1991
PubMed

Insights

Chloramphenicol, a broad-spectrum antibiotic, carries a rare risk of aplastic anemia and resistance. Due to these safety concerns, its veterinary use is restricted, particularly in food-producing animals.

Area of Science:

  • Pharmacology
  • Toxicology
  • Infectious Diseases

Background:

  • Chloramphenicol is a broad-spectrum antibiotic widely used in human and veterinary medicine since the late 1940s.
  • Its use is linked to a rare, idiosyncratic aplastic anemia in humans, a potentially fatal adverse effect.
  • Concerns also include the selection of chloramphenicol-resistant pathogens.

Purpose of the Study:

  • To review the safety profile of chloramphenicol.
  • To discuss the implications of adverse effects and resistance on its clinical use.
  • To outline current regulatory restrictions on chloramphenicol in veterinary practice.

Main Methods:

  • Literature review of chloramphenicol's history, adverse effects, and resistance patterns.
  • Analysis of regulatory actions and restrictions on its use.
  • Examination of its application in medical and veterinary fields.

Main Results:

  • Chloramphenicol's use is associated with idiosyncratic aplastic anemia, even with topical and occupational exposure.
  • The risk of aplastic anemia and antimicrobial resistance has led to significant restrictions.
  • In Australia, chloramphenicol is restricted to small animals and prohibited in food-producing animals like horses.

Conclusions:

  • The potential for severe adverse effects and resistance necessitates careful consideration of chloramphenicol use.
  • Regulatory restrictions aim to mitigate risks to human health and prevent the spread of resistant bacteria.
  • Current guidelines prioritize safer alternatives and limit chloramphenicol to specific non-food-producing animal populations.

More Related Videos

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...